Insider Activity of Prior Stephen David
According to the SEC Form 4 filings, Prior Stephen David, being in a position of
- Chief Strategy Officer at AN2 Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 2029 shares for $2,721,over all time since 2025-01-03, has bought 0 shares, and sold 2029 shares for $2,721.
The largest sale of all time was on 2025-01-03 and amounted to 2029 shares of AN2 Therapeutics, Inc. for $2,721.
Biography of Prior Stephen David
No biography is available at this moment.